Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.
OHE at AES 2016: Early Access Schemes, Equity Adjusted QALYs, Multi-indication Pricing and Formulary Development
2 August 2016
The Spanish Health Economics Association (AES) Conference was held at the University of Murcia, 15-18th June 2016. The topic of the meeting was “Reforms under the…
OHE is Pleased to Host Four MSc Students for 2016
26 July 2016
OHE is pleased to be working with four MSc students this year. The students, from City University and the London School of Economics, will spend three…
OHE Awarded Funding for Seven Projects by the EuroQol Research Foundation
18 July 2016
OHE is set to work on seven new projects funded by the EuroQol Research Foundation. The work will cover a range of topics from understanding the…
OHE Workshop: Surrogate Endpoints as Predictors of Overall Survival in Oncology
14 July 2016
On Tuesday 28th June 2016 OHE held a workshop on the topic of surrogate endpoints as predictors of overall survival in oncology. The workshop was commissioned…
OHE and ABPI Webinar: New EQ-5D-5L value sets for England and the UK and Implications for HTA
11 July 2016
The Association of the British Pharmaceutical Industry, in conjunction with the Office of Health Economics, invites you to register for a webinar on Monday 18th July:…
The Value of Knowing and Knowing the Value: Improving the Health Technology Assessment of Complementary Diagnostics
5 July 2016
“Complementary diagnostics” are defined as tests using biomarkers for risk assessment, diagnosis, prognosis, monitoring, and guiding therapeutic decisions. This White Paper presents a more comprehensive framework for considering their value contribution.
Age, Utilities, and Self-Reported Health: Issues for HTA
28 June 2016
On Wednesday 18th May OHE’s Patricia Cubi-Molla presented an OHE Lunchtime Seminar on age, utilities and self-reported health. This post contains a short summary and the…
OHE at ISPOR Washington DC (2): EQ-5D and Valuing Health Gains.
10 June 2016
This is part two of two posts containing posters and presentations by members of the OHE team at ISPOR’s 21st Annual International Meeting held in Washington…
OHE at ISPOR Washington DC (1): HTA, Evidence and Pricing
9 June 2016
This is part one of two posts containing posters and presentations by members of the OHE team at ISPOR’s 21st Annual International Meeting held in Washington…